in America, nearly 100,000 people are waiting for an organ transplant

CONCORD MONITOR
May 14, 2008 – 7:03 am

At any given time in America, nearly 100,000 people are waiting for an organ transplant. Yesterday a chilling story in The Boston Globe demonstrated how desperate the ill can become, lingering on the waiting list for years. Two patients, a 57-year-old man and a 70-year-old woman, each agreed to accept a kidney from a deceased donor whose organs were approved under new “expanded” criteria. The kidneys they received came from a 49-year-old homeless man.

The tight transplant timetable and the cost of running the multitude of tests that can now be performed means that most organs are tested only for some of them – AIDS and hepatitis, for example. The homeless donor, however, carried a rare virus that is usually found in rats. The female transplant patient died and, as of yesterday, the male patient was fighting for his life.

When the alternative is death, most patients and most medical professionals are willing to gamble. At least one study has found that recipients who are older and people who received organs approved under the expanded standards – like those from an older donor or someone with high blood pressure – face only a slightly elevated risk.

Medical progress ensures that organ demand always outstrips the supply. That’s creating ethical dilemmas that need to be resolved. It is illegal to sell a human organ but legal to donate one.

It is permissible to specify the recipient of one’s organ, allowing that person to jump ahead of others whose time may be shorter. But people often advertise widely for an donated organ using a particularly poignant story that may or may not be accurate. Should they be allowed to shortcut the process designed to make sure that organs go to those whose need is most urgent?

Should it be illegal to sell a human organ? The director of bioethics studies at the libertarian Cato Institute and others with faith in market solutions to problems believes that it should be, given informed consent. If it saves lives, and it no doubt would, shouldn’t the sale of an organ or organ tissue be allowed?

To increase the supply of viable organs for transplant, the meaning of death is being reclassified to include not just “brain death” but cardiac arrest. There is, however, disagreement over how long a person’s heart must remain stopped before death can be declared and organs removed.

These questions will take on added urgency as baby boomers age and more older patients seek and benefit from organ transplants. But an end to such dilemmas is looking more likely all the time.

Scientists have grown skin, bone, cartilage and blood vessels for transplant in patients. In 2006, Boston researchers successfully grew and implanted tissue that formed roughly half the bladders of seven young patients. And this year, a University of Minnesota research team revealed that it had taken the valves and “architecture” of a heart from a dead rat that had been scrubbed of all its cells and seeded it with cells from a newborn rat. Within months, in a petri dish in their lab, a new rat heart was beating and pumping a small amount of blood.

The feat, Dr. Doris Taylor told The New York Times, “opens the door to this notion that you can make any organ: kidney, liver, lung, pancreas – you name it and we hope we can make it.”

For tens of thousands of people, that day can’t come soon enough. In the meantime, unless many more people sign up to be organ donors, the only hope for some patients lies in accepting an organ from a homeless donor.

Gujarat recommends doc’s name for Nobel




Gujarat recommends doc’s name for Nobel



EXPRESS NEWS SERVICE



AHMEDABAD, Nov 14: Kidney transplants are no
doubt one of modern medicine’s greatest contributions to human
survival. Yet, like all scientific milestones, these too spin off their
own set of perils for a patient.Very often, the body rejects the new
kidney, and a patient is required to invest in a host of remedial
drugs: a problem that doctors and patients had simply reconciled to,
all these years.

Dr
H L Trivedi, director and professor, Institute of Kidney Diseases and
Research Centre, Ahmedabad, received many such patients, and knew
precisely what the situation meant, in a country where people could
barely afford the transplant itself.

But
for a thinking mind, no challenge is insurmountable. And Dr Trivedi
took it upon himself to find a solution to the vexation, and with his
team at the institute, set about to find a way that could do away with
an expensive regimen of drugs a patient is required to take to prevent
kidney rejection.The doctors introduced the donor’s bone marrow cells
in patients, andfound they created tolerance. A subsequent kidney
transplant will not be rejected by the body, they found.

The Gujarat Government has recommended Dr Trivedi’s name for the Nobel Prize for Medicine for this discovery.

Dr
Trivedi took cue from Nobel Prize-winning Swiss immunologist Professor
Zinkernagel, who concluded from experiments on animals that only a
small portion of the immune system, when exposed to virus, reacts and
eventually becomes tolerant.

“I
thought the principle can be applied to humans too,” he says.Though
the idea originated in 1995, the experiments began this September.
Using the breakthrough technique, 12 patients underwent kidney
transplantation. “The patients are on a very small level of drugs and
are doing so well,” he says.

Dr
Trivedi adds, “Though drugs block rejection of the transplanted
kidney, they make the patient vulnerable to virus infections and
cancers.” The post-transplant drugs cost Rs 4 lakh to Rs 5 lakh, he
says.

According to Dr Trivedi, the patients caneschew drugs after two months, saving a considerable sum by way of drug purchases.

“This will change the therapeutic way that transplants are carried out,” he says.

Health
and Family Welfare Minister Ashok Bhatt confirmed that Dr Trivedi’s
name has been recommended for the Nobel Prize. A detailed research
paper is underway, to be sent to reputed international scientific
journals.

Copyright © 1998 Indian Express Newspapers (Bombay) Ltd.

Organ transplant problems should be addressed urgently

There are lakhs of patients waiting for organ transplant in the country. Government should view the problem seriously. It would be an important step in health and family welfare if government set up a task force to study the problems of organ shortage in the country. Organ theft has forced the government to take the extreme steps in formulating laws that restrict organ transplants from unrelated donors.

The remedy has actually become as cruel as the problem. The laws and machinery that has been created for controlling organ transplant has severly reduced organ supply and has been affecting the hapless patients waiting for transplant. Thousands of patients die for want of organs like kidney. Government is doing absolutely nothing at present to address the problems of patients who can be saved through organ transplant

When the news of a Gujarat doctor applying stem cells during transplantation came out so many enquiries for patients came, showing the great demand for treatments and therapies for the kidney patients.

Government should remove the defects and shortcomings in the present organ transplant regulations to enable improved availablity of organs for the patients.

Remember, need for organ can happen to anybody.We should be aware of the dangers of not addressing the problem.

Sreekumar

Indian doctor’s new stem cells technique for kidney transplant

Health
Sunday, July 16, 2006

Indian doctor’s new stem cells technique for kidney transplant

From correspondents in Gujarat, India, 12:45 PM IST

Ahmedabad – A doctor in Gujarat claims he has pioneered a technique
of kidney transplantation using human embryonic stem cells that not
only overcomes the problem of organ rejection but also cuts treatment
cost dramatically.

Researchers across the world have been
grappling with the problem of rejection of the kidney transplanted in
the recipient. To overcome this situation, patients are given strong
immunosuppressants that leave them vulnerable to infections as they
lower immunity.

However, H.L. Trivedi of the Civil Hospital here
says his procedure does away with the need of immunosuppressants, thus
lowering the cost of the transplantation.

The treatment cost
comes down to Rs.100,000 ($2,100) from the present about Rs.1 million
($21,600). Expenditure on subsequent maintenance is also reduced from
around Rs.15,000 to a mere Rs.300.

‘Though work is going on in
Harvard, Stanford and Pittsburgh, we are the first in the world to use
human embryonic stem cells to generate new equivalent cells in
laboratory,’ Trivedi, director of the Institute of Kidney Diseases and
Research Centre at the hospital, told IANS.

Human embryonic stem
cells have the ability to develop into any other cell produced in the
human body. Thus they have the potential to treat a range of diseases
including Parkinson’s, Alzheimer’s, diabetes, heart disease, stroke,
spinal cord injuries and burns.

Kidney failure has emerged as the third most common killer across the world after cancer and heart diseases.

The
technique used by Trivedi and his team of doctors comprising Vineet
Mishra, Aruna Vanikar, Pranjal Modi and Veena Shah has given a new
lease of life to 20 patients not only from India but also Nigeria and
Kenya and the US who are afflicted with kidney failure, he said.

The
procedure essentially entails growing in the laboratory human embryonic
stem cells that have been derived from the female who is donating the
kidney. These stem cells are then co-cultured with the same person’s
bone marrow cells. This gives them ‘direction’ to develop into bone
marrow cells.

These cells are then infused into the recipient’s
liver and protect the kidney from rejection when it is transplanted.
Patients can resume normal activity within 10 days of the operation.

Ten-year-old
Riya Patel, Trivedi’s youngest patient, bears witness to the efficacy
of the procedure. With both her kidneys having failed, her US-based
parents approached several doctors in Nadiad of Kheda district,
adjoining Ahmedabad, where their relatives came to know about Trivedi.

‘Our
anxiety vanished after we talked to Dr. Trivedi,’ said Riya’s mother
Kavita, who donated her kidney to her daughter. Riya was operated upon
June 1 and has recovered well. ‘Riya is active like other children and
all her reports are normal,’ said her parents, who hope to soon take
their daughter with them to the US.

Nalin, 34, too had consulted
many doctors after his kidneys failed. Now, a fortnight after his
operation, the welder from the coastal town of Porbander in western
Gujarat said he was feeling fine.

‘He could not even walk before.
But now he is able to move about,’ said his wife Jyoti who donated her
kidney for the transplant. ‘Doctor sahe

b is like god for us,’ she said.